RR Ellison
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Myeloid Leukemia Research 8
-
- Acute Lymphoblastic Leukemia research 7
- Co-authors
- B P Alter (1 shared paper)James F. Holland (2 shared papers)Charles Alan Schiffer (1 shared paper)Robert W. Carey (1 shared paper)Roger B. Davis (1 shared paper)CJ Jr Cornell (1 shared paper)Lewis R. Silverman (1 shared paper)RS Weinberg (1 shared paper)
- Journals
- Blood (7 papers)Journal of Clinical Oncology (1 paper)PubMed (2 papers)
- Partner nations
- United States
In The Last Decade
RR Ellison
10 papers receiving 1.5k citations
RR Ellison's Hit Papers
Peers
Comparison fields: 5 of 54
- Hematology 1.3k
- Public Health, Environmental and Occupational Health 620
- Genetics 218
- Oncology 351
- Emergency Medicine 65
Countries citing papers authored by RR Ellison
This map shows the geographic impact of RR Ellison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RR Ellison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RR Ellison more than expected).
Fields of papers citing papers by RR Ellison
This network shows the impact of papers produced by RR Ellison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RR Ellison. The network helps show where RR Ellison may publish in the future.
Co-authors
The 25 scholars most cited alongside RR Ellison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study Hit paper breakdown → | 1982 | 437 |
| 2 | 1981 | 394 | |
| 3 | 1981 | 353 | |
| 4 | Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes. | 1993 | 190 |
| 5 | 1984 | 105 | |
| 6 | 1988 | 74 | |
| 7 | 1982 | 29 | |
| 8 | 1984 | 9 | |
| 9 | 1985 | 6 | |
| 10 | Failure of hydroxyurea (NSC-32065) and prednisone (NSC-10023) in the treatment of acute myelocytic leukemia. | 1971 | 1 |
About RR Ellison
RR Ellison is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Oncology and Pediatrics, Perinatology and Child Health, having authored 10 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers), Neutropenia and Cancer Infections (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Mast cells and histamine (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Hemoglobinopathies and Related Disorders (1 paper). The work is most often cited by research in Hematology (1.3k citations), Public Health, Environmental and Occupational Health (620 citations), Genetics (218 citations), Oncology (351 citations) and Emergency Medicine (65 citations). RR Ellison has collaborated with scholars based in United States. Frequent co-authors include B P Alter, James F. Holland, Charles Alan Schiffer, Robert W. Carey, Roger B. Davis, CJ Jr Cornell, Lewis R. Silverman, RS Weinberg, Janet Cuttner and Howard R. Terebelo. Their work appears in journals such as Blood, Journal of Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.